TCTMD (registration) Bivalirudin does not reduce 30-day mortality rates compared with heparin in patients undergoing PCI without planned use of glycoprotein IIb/IIIa inhibitors (GPIs), according to a meta-analysis presented Sunday at TCT 2014. There was a lower risk of ... and more »
2 Minute Medicine Although the current standard of DVT prophylaxis for cancer patients is 6 months of low-molecular weight heparin (LMWH), residual vein thrombosis (RV...
pharmabiz.com Unethical practice of dispensing cheap substitutes of low molecular weight heparin to patients, suffering from cardiac arrest, is found to be flourishing in several parts of India. These products are being sold at four times the actual cost by evading ...
Medscape WASHINGTON, DC — More than five months after the HEAT-PPCI STEMI trial of heparin monotherapy vs bivalirudin burst onto the radar of interventional cardiologists, the two men at opposite ends of this controversy took to the public stage to debate the ...
7thSpace Interactive (press release) IntroductionThere are approximately 19 million new cases of sepsis worldwide each year. Among them, more than one-quarter of patients die. We aimed to assess the effects of heparin on short term mortality in adult patients with sepsis and severe sepsis.
Monthly Prescribing Reference Hospira has announced a voluntary nationwide user-level recall of one lot of Heparin Sodium, 1,000 USP Heparin Units/500mL (2 USP Heparin Units/mL), in 0.9% Sodium Chloride Injection, 500mL, due to a confirmed customer report of particulate in a single ... and more »
Medscape WASHINGTON, DC — US cardiologists attending TCT 2014 finally got a first-hand look at the Chinese BRIGHT trial, heralded as the first randomized trial to compar...
AAP News (subscription) One lot of heparin sodium injection is being recalled due to the presence of a foreign particle in one unit. Hospira Inc., of Lake Forest, Ill....
FiercePharma Manufacturing The FDA has kept a close eye on Chinese heparin makers ever since tainted crude heparin from China was tied to the deaths of dozens of dialysis patients in the U.S. The agency has now taken steps against a Chinese heparin maker it says is using ...
